Evidence map›Paper›PMID 34641314›Full record

ArticleMolecules (Basel, Switzerland)2021

Nabeelah Bibi Sadeer, Juliano G Haddad, Mohammed Oday Ezzat, Philippe Desprès, Hassan H Abdallah, Gokhan Zengin, Ahmet Uysal, Chaker El Kalamouni, Monica Gallo, Domenico Montesano and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Antiviral Effect ofPharmaceuticals (Basel, Switzerland) · 2022
    Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 5 countries.

Nabeelah Bibi SadeerDepartment of Health Sciences, Faculty of Medicine and Health Sciences, University of Mauritius, Réduit 80837, Mauritius.ORCID 0000-0002-0602-0059
Juliano G HaddadUnité Mixte Processus Infectieux en Milieu Insulaire Tropical, Plateforme Technologique CYROI, Université de la Réunion, INSERM U1187, CNRS UMR 9192, IRD UMR 249, 94791 Sainte Clotilde, La Réunion, France.ORCID 0000-0001-5035-0162
Mohammed Oday EzzatDepartment of Chemistry, College of Education for Women, University of Anbar, Ramadi 31001, Iraq.
Philippe DesprèsUnité Mixte Processus Infectieux en Milieu Insulaire Tropical, Plateforme Technologique CYROI, Université de la Réunion, INSERM U1187, CNRS UMR 9192, IRD UMR 249, 94791 Sainte Clotilde, La Réunion, France.ORCID 0000-0001-8926-4050
Hassan H AbdallahChemistry Department, College of Education, Salahaddin University-Erbil, Erbil 44001, Iraq.ORCID 0000-0002-9198-0475
Gokhan ZenginDepartment of Biology, Science Faculty, Selcuk University, Campus, 42130 Konya, Turkey.ORCID 0000-0001-6548-7823
Ahmet UysalDepartment of Medicinal Laboratory, Vocational School of Health Services, Selcuk University, 42130 Konya, Turkey.
Chaker El KalamouniUnité Mixte Processus Infectieux en Milieu Insulaire Tropical, Plateforme Technologique CYROI, Université de la Réunion, INSERM U1187, CNRS UMR 9192, IRD UMR 249, 94791 Sainte Clotilde, La Réunion, France.ORCID 0000-0003-4673-6614
Monica GalloDepartment of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, via Pansini 5, 80131 Naples, Italy.ORCID 0000-0001-6281-426X
Domenico MontesanoDepartment of Pharmacy, University of Naples Federico II, via D. Montesano 49, 80131 Naples, Italy.ORCID 0000-0002-8857-2091
Mohamad Fawzi MahomoodallyDepartment of Health Sciences, Faculty of Medicine and Health Sciences, University of Mauritius, Réduit 80837, Mauritius.ORCID 0000-0003-3962-8666
Centre National de la Recherche Scientifique · FRSelçuk University · TRUniversity of Mauritius · MUUniversity of Naples Federico II · ITSalahaddin University-Erbil · IQUniversity of Anbar · IQ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The recent emergence of Zika virus (ZIKV) in Brazil and the increasing resistance developed by pathogenic bacteria to nearly all existing antibiotics should be taken as a wakeup call for the international authority as this represents a risk for global public health. The lack of antiviral drugs and effective antibiotics on the market triggers the need to search for safe therapeutics from medicinal plants to fight viral and microbial infections. In the present study, we investigated whether a mangrove plant,

Indexed as

Anti-Bacterial AgentsAntifungal AgentsAntiviral AgentsBrazilCandida albicansComputer SimulationDrug SynergismEscherichia coliKlebsiella pneumoniaeMauritiusMicrobial Sensitivity TestsMicrobial ViabilityPlant ExtractsProteus mirabilisPseudomonas aeruginosaRhizophoraceaeAnti-Bacterial AgentsAntifungal AgentsAntiviral AgentsPlant ExtractsADMEantimicrobialantiviralenvelope proteinmangrove plantspharmacokinetics

Identifiers

PMID34641314
PMCPMC8510246
OpenAlexW3199870856

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.